Integra Lifesciences Holdings (IART) R&D In Process (2019)
Integra Lifesciences Holdings recorded quarterly R&D In Process of $5.0 million in Q4 2019, down 91.65% quarter-over-quarter from $59.9 million in Q3 2019.
Integra Lifesciences Holdings' R&D In Process history runs 1 years deep, the most recent figure standing at $5.0 million for Q4 2019.
- In Q4 2019, R&D In Process changed N/A year-over-year to $5.0 million; the TTM figure through Dec 2020 stood at $64.9 million (changed 0.0% YoY), while the FY2019 annual figure was $5.0 million, changed N/A from the prior year.
- R&D In Process came in at $5.0 million for Q4 2019 at Integra Lifesciences Holdings, down from $59.9 million in the prior quarter.
- In the past five years, R&D In Process ranged from a high of $59.9 million in Q3 2019 to a low of $5.0 million in Q4 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D In Process (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Integra Lifesciences Holdings | 1.20 Bn | 939.16 Mn | 216.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 5.00 Mn |
| Sep 30, 2019 | 59.89 Mn |